Page 326 - 00. Complete Version - Progress Report IPEN 2014-2016
P. 326

326   Materials and Nanotechnology | Progress Report





               played an important role.                      for treatment in cultured cells or in animals
                                                              with induced tumors.
               The use of gold nanoparticles from 198Au is
               already a reality. The ability of this metal to   Development of Gold nanoparticles as
               be used both as a contrast agent for diagno-   radiation sensitizers in cancer therapy
               sis and as a therapeutic agent classifies it in   and as internal nanodosimeter
               the class of agent for “theranostic”. Katti and
               colleagues have demonstrated that nanopar-
               ticles formed from 198Au are highly effective
               in the treatment of prostate cancer, a method
               proposed by him to prepare these nanoparti-
               cles using molecules obtained directly from
               natural products such as green tea (epigallo-
               catechin- 3-gallate), drawing even more at-    Figure 49. 198AuNps en-  Figure 50.   Internalization in PC-e
               tention to these materials, however little was   capsulated with Albumin   cells of Au nanoparticles conju-
                                                              by coupling with3-MPA  gated with CD-163 mimic.
               presented on the yield and stability of this
               method, besides forming nanoparticles with     Every year, many millions of people world-
               great dispersion of size.                      wide are diagnosed with cancer and there are
                                                              a high percentage of deaths from the disease.
               We have recently developed a method capa-      Even the survivors of the cancer treatment
               ble of generating gold nanoparticles with siz-  have serious deleterious heath effect due to
               es around 14 nm, very stable (zeta potential   chemotherapy and radiotherapy. Radiation
               greater than -30 mV) and with a yield great-   therapy is very aggressive, but it is an increas-
               er than 99.7% using a gold leaf (Figure48). It   ing important tool to fight cancer. It is still a
               is therefore intended to apply such materials   great challenge in radiation therapy to Deliver
               in vitro and in vivo tests for the treatment of   the proper curative dose of radiation to tumor
               both prostate cancer and bladder cancer.       while sparing normal tissues from radiation.
                                                              We have recently developed a method capa-
                                                              ble of generating gold nanoparticles with siz-
                                                              es around 14 nm, very stable (zeta potential
                                                              greater than -30 mV) and with a yield great-
                                                              er than 99.7% using a gold leaf. It is therefore
                                                              intended to apply such materials in vitro and
                                                              in vivo tests for the treatment of both pros-
                                                              tate cancer and bladder cancer.


                                                              To this end, the 198AuNps were prepared and
                                                              encapsulated with Albumin, by direct physio
               Figure 48
                                                              absorption effect and with the use of coupling
               To this end, the 198AuNps will be prepared and,   agents (3-MPA) (Figure 49). Gold nanoparti-
               in collaboration with the Laboratory of Nucle-  cles were also conjugated with a new peptide
               ar Medicine of the University of São Paulo, to-  (CD163 mimic) developed by Dr. Rosemeire Sil-
               gether with Dr. Fabio Luiz Navarro Marques,    va for internalization studies in prostate can-
               will be tested both as diagnostic agents and   cer cells and pancreatic cancer cells (Figure 50).





                         Instituto de Pesquisas Energéticas e Nucleares
   321   322   323   324   325   326   327   328   329   330   331